Company Filing History:
Years Active: 2023-2025
Title: The Innovative Contributions of Douglas E. Brough
Introduction
Douglas E. Brough is a notable inventor based in Germantown, MD, with a focus on developing advanced vaccine technologies. He holds three patents that reflect his commitment to improving public health through innovative solutions. His work primarily revolves around engineered molecular vaccine constructs aimed at combating viral infections.
Latest Patents
Among his latest patents, Brough has developed constructs for human papillomavirus (HPV) vaccines. These engineered vaccines include ligand-inducible gene switch systems that can modulate the expression of heterologous genes, such as cytokines, in host cells. Additionally, he has worked on hepatitis B vaccines, which also utilize similar engineered constructs to enhance immune responses against the virus.
Career Highlights
Brough's career is marked by his association with Precigen, Inc., where he contributes to groundbreaking research in vaccine development. His innovative approaches have positioned him as a key figure in the field of molecular biology and immunology.
Collaborations
Throughout his career, Brough has collaborated with talented individuals such as Cheryl G. Bolinger and Ramya Yarlagadda. These partnerships have fostered a collaborative environment that enhances the development of effective vaccine technologies.
Conclusion
Douglas E. Brough's contributions to vaccine innovation are significant and impactful. His work continues to advance the field of immunology, providing new avenues for combating viral diseases.